Peter Greenleaf
2013 - Histogenics
In 2013, Peter Greenleaf earned a total compensation of $456.5K as Former Director, President and Chief Executive Officer at Histogenics.
Compensation breakdown
Option Awards | $230,967 |
---|---|
Salary | $196,575 |
Other | $28,957 |
Total | $456,499 |
Greenleaf received $231K in option awards, accounting for 51% of the total pay in 2013.
Greenleaf also received $196.6K in salary and $29K in other compensation.
Rankings
In 2013, Peter Greenleaf's compensation ranked 9,647th out of 12,286 executives tracked by ExecPay. In other words, Greenleaf earned more than 21.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,647 | 22nd |
Manufacturing | 3,573 | 23rd |
Chemicals And Allied Products | 1,129 | 23rd |
Drugs | 876 | 24th |
Biological Products, Except Diagnostic Substances | 148 | 25th |
Greenleaf's colleagues
We found three more compensation records of executives who worked with Peter Greenleaf at Histogenics in 2013.
News
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
April 18, 2022
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
May 10, 2021
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019